3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
19
Myelodysplastic Syndromes
7
Leukemia, Hairy Cell
4
Leukemia, Biphenotypic, Acute
4
Recurrence
3
Leukemia
3
Sarcoma, Myeloid
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Blast Crisis
2
Targeted Therapy
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myasthenia Gravis
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cyclophosphamide
22
Dexamethasone
15
Cytarabine
14
venetoclax
13
Vincristine
13
Methotrexate
10
Etoposide
10
Prednisone
9
Doxorubicin
9
Calcium Dobesilate
9
prednylidene
8
dexamethasone acetate
8
dexamethasone 21-phosphate
8
deltacortene
8
auricularum
8
merphos
7
Specimen Handling
7
pegaspargase
6
fludarabine phosphate
6
daratumumab
6
calaspargase pegol
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
fludarabine
5
Stem Cell Transplantation
5
Filgrastim
5
Daunorubicin
5
Bortezomib
5
Biopsy
5
Asparaginase
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Cladribine
×
1 year
×
Clear all
No trials found.